Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 2,510 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Autism Spectrum Disorder
Interventions: Balovaptan, Esomeprazole; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Cardiac Arrest
Interventions: Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators, Systematic bystander resuscitation instruction by 911 operators, Comprehensive community training of lay people in CPR and AED use., Optimized first responder performance including earlier use of AEDs.; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 20,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: HIV/AIDS, Gender, Behavior and Behavior Mechanisms
Interventions: Not listed
Lead sponsor: Hektoen Institute for Medical Research; Other
Eligibility: 15 Years to 24 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Denver, Colorado • Chicago, Illinois • Philadelphia, Pennsylvania

Conditions: Food Selection, Attitude
Interventions: Low Climate Impact label, High Climate Impact label; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 5,055 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Microbiome Analysis, Metabolomics
Interventions: Freeze-dried blueberry powder beverage; Other
Lead sponsor: Colorado State University; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Healthy Participants
Interventions: Perampanel; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 20 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Anaheim, California

Conditions: Healthy
Interventions: Midazolam Alone, Qualaquin (quinine) alone steady state, Midazolam and Qualaquin at steady state; Drug
Lead sponsor: Mutual Pharmaceutical Company, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Fibromyalgia
Interventions: The Whole Body Hyperthermia system uses water-filtered infrared-A (wIRA) heat radiation; Device
Lead sponsor: Charles (Chuck) Raison; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2015
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Abscess, Fracture
Interventions: Ketamine; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 2 Years to 17 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: SARS-CoV-2 Infection, Influenza A, Influenza B, RSV
Interventions: Flu A/B/COVID-19 + RSV Multiplex Rapid Test; Device
Lead sponsor: CorDx, Inc.; Industry
Eligibility: 6 Months and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Alpharetta, Georgia

Conditions: Seizures Associated With EMAS
Interventions: GWP42003-P, Placebo; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 1 Year to 18 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 10
States / cities: Birmingham, Alabama • Sacramento, California • Atlanta, Georgia + 7 more

Conditions: Diabetes, Hypertension, HIV
Interventions: HIV testing, General Health Screen; Behavioral
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: HIV Infections
Interventions: mLab App, HIV Prevention Information, HIV Home Tests; Device · Behavioral
Lead sponsor: Rebecca Schnall, RN, MPH, PhD; Other
Eligibility: 18 Years to 29 Years · Male only
Enrollment: 525 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Chicago, Illinois • New York, New York

Conditions: Preterm Infant
Interventions: Early/Slow, Early/Fast, Late/Slow, Late/Fast; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Up to 32 Weeks
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Healthy Adults
Interventions: Crucera-SGS, Meriva 500-SF; Dietary Supplement
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Veterans With Opioid Use Disorder
Interventions: Treatment As Usual Vocational Rehabilitation (TAU-VR), Individual Placement and Support (IPS); Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years and older
Enrollment: 123 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: Birmingham, Alabama • Tuscaloosa, Alabama

Conditions: Peripheral Arterial Disease, Critical Limb Ischemia
Interventions: BOLD-MRI; Other
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 19 Years to 89 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: HIV Infections, Hepatitis B Infections, Hepatitis C Infections
Interventions: Multiplo HBc/HIV/HCV and Reveal HBsAg; Device
Lead sponsor: MedMira Laboratories Inc.; Industry
Eligibility: 13 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: Los Angeles, California • Miami, Florida • Minneapolis, Minnesota + 1 more

Conditions: Lymphoma, Melanoma, Neoplasm Metastasis, Renal Cell Carcinoma
Interventions: COL-3; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Talaromycosis
Interventions: Liposomal Amphotericin B (LAmB), Flucytosine (5FC), Flucytosine (5FC) placebo pill, Deoxycholate Amphotericin B (DAmB); Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Schizophrenia, Negative Type; Schizophrenic, Schizo Affective Disorder
Interventions: repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 55 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Double Outlet Right Ventricle, Transposition of the Great Arteries, Truncus Arteriosus, Congenitally Corrected Transposition of the Great Arteries
Interventions: 3D Printed Heart Model; Diagnostic Test
Lead sponsor: Children's National Research Institute; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 3
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Philadelphia, Pennsylvania

Conditions: Stroke, Hemiparesis, Walking, Difficulty
Interventions: Augmented Feedback without Virtual Reality(VR, Augmented Feedback with Non-Game based VR, Augmented Feedback with Game based VR; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: Not listed
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: Obesity, Childhood
Interventions: Educational Handout, Video Series, Group Discussion Sessions; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan in Healthy Volunteers

RACE-CARS - RAndomized Cluster Evaluation of Cardiac ARrest Systems

Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development

Do Sustainability Labels Lead to More Sustainable and Healthier Food Choices?

Influence of the Gut Microbiome on Blueberry Polyphenol Metabolites

Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects

Drug-Drug Interaction Study of Qualaquin and Midazolam

Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia

Study to Find the Dose of Rapidly Administered Ketamine for Brief Painful Procedures in Children

Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

Project Wellness: Increasing HIV Testing Among West African Immigrants

Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)

Testing Four Feeding Approaches to Oral Feeding in Preterm Infants

Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin

Together in Recovery With Veterans Through Employment

BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI

Rapid Diagnostics for HIV and Hepatitis

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)

Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia

Clinical Impact of Rapid Prototyping 3D Models for Surgical Management

Effects of Different Types of Augmented Feedback on Intrinsic Motivation and Spatiotemporal Gait Performance After Stroke

Storytelling To Prevent Obesity and Encourage Responsive Feeding Practices in Young Children